NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia

Leuk Lymphoma. 2017 Mar;58(3):732-735. doi: 10.1080/10428194.2016.1211278. Epub 2016 Aug 11.

Authors

Brianan McGovern¹, Fiona Quinn², Clare Andrews³, Michael Jeffers¹, Christopher L Bacon^{2

3}, Brian Bird⁴, Gerard Crotty⁵, Elisabeth Vandenberghe^{2

3}, Richard Flavin^{1

2}

Affiliations

¹ a Department of Histopathology , St. James's Hospital , Dublin , Ireland.
² b Department of Cancer Molecular Diagnostics , St. James's Hospital , Dublin , Ireland.
³ c Department of Haematology , St. James's Hospital , Dublin , Ireland.
⁴ d Department of Medical Oncology , Bons Secours Hospital , Cork , Ireland.
⁵ e Department of Haematology , Midland Regional Hospital , Tullamore , Ireland.

PMID: 27686521
DOI: 10.1080/10428194.2016.1211278

No abstract available

Publication types

Letter

MeSH terms

Aged
Alleles
Biomarkers
Bone Marrow / pathology
Cell Transformation, Neoplastic / genetics*
Disease Progression
Female
Genes, Immunoglobulin
Hodgkin Disease / diagnosis
Hodgkin Disease / pathology*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Male
Middle Aged
Mutation*
Receptor, Notch1 / genetics*

Substances

Biomarkers
Receptor, Notch1